Edition:
India

Merck KGaA (MRCG.DE)

MRCG.DE on Xetra

89.18EUR
2:22pm IST
Change (% chg)

€-0.62 (-0.69%)
Prev Close
€89.80
Open
€89.90
Day's High
€89.90
Day's Low
€89.11
Volume
39,332
Avg. Vol
566,048
52-wk High
€115.20
52-wk Low
€89.04

Chart for

About

Merck KGaA is a Germany-based company engaged in the pharmaceutical industry. The Company operates through four business segments: Merck Serono; Consumer Health; Merck Millipore, and Performance Materials. Within the Merck Serono division, the Company focuses on therapeutic areas and prescription drugs of chemical and biotechnol... (more)

Overall

Beta: 1.01
Market Cap(Mil.): €12,352.97
Shares Outstanding(Mil.): 129.24
Dividend: 1.20
Yield (%): 1.26

Financials

  Industry Sector
P/E (TTM): -- 31.15 16.44
EPS (TTM): -- -- --
ROI: -- 14.99 10.62
ROE: -- 16.33 14.20

BRIEF-Orexigen Therapeutics announces commercialization and distributorship agreement with Merck KGaA, Darmstadt

* Orexigen Therapeutics announces commercialization and distributorship agreement with Merck KGaA, Darmstadt, Germany for contrave in Latin America

13 Nov 2017

Merck KGaA has contacted prospective buyers of consumer health

FRANKFURT Germany's Merck KGaA said it has sent information documents on its consumer health business to prospective buyers, kicking off an auction, even as a much larger rival business is about to come to market.

09 Nov 2017

Merck KGaA has contacted prospective buyers of consumer health

FRANKFURT, Nov 9 Germany's Merck KGaA said it has sent information documents on its consumer health business to prospective buyers, kicking off an auction, even as a much larger rival business is about to come to market.

09 Nov 2017

UPDATE 1-Merck KGaA tones down outlook but consumer health shines

* Sales, profit to hit lower end of target ranges on strong eur

09 Nov 2017

CORRECTED-BRIEF-Merck KGaA, Samsung Biologics sign MoU on strategic alliance

* Says MilliporeSigma signs memorandum of understanding (MoU) with Samsung Biologics for strategic alliance on biopharma manufacturing, biologics process development‍​

03 Nov 2017

GSK may bid for Pfizer consumer unit, stoking dividend fears

LONDON GlaxoSmithKline will look at acquisition options to bulk up its consumer health business as rivals like Pfizer and Merck KGaA quit the field, its chief executive said on Wednesday.

25 Oct 2017

GSK may bid for Pfizer consumer unit, stoking dividend fears

LONDON GlaxoSmithKline will look at acquisition options to bulk up its consumer health business as rivals like Pfizer and Merck KGaA quit the field, its chief executive said on Wednesday.

25 Oct 2017

BRIEF-Merck KGaA: Canadian patent office to grant patent application for CRISPR technology

* MERCK KGAA - CANADIAN PATENT OFFICE TO GRANT MERCK KGAA, DARMSTADT, GERMANY'S PATENT APPLICATION FOR CRISPR TECHNOLOGY

24 Oct 2017

German stocks - Factors to watch on October 4

FRANKFURT, Oct 4 The following are some of the factors that may move German stocks on Wednesday:

04 Oct 2017

Police search Merck KGaA's French plant in thyroid pill inquiry

LYON, France French police searched German drugmaker Merck KGaA's plant in Lyon on Tuesday as part of an investigation into complaints by patients about changes to its thyroid drug Levothyrox, a company spokeswoman said.

03 Oct 2017

Earnings vs. Estimates